Articles | Volume 9, issue 4
https://doi.org/10.5194/jbji-9-191-2024
https://doi.org/10.5194/jbji-9-191-2024
Brief report
 | 
24 Jul 2024
Brief report |  | 24 Jul 2024

Emergence of rifampicin-resistant staphylococci on the skin and nose of rifampicin-treated patients with an orthopaedic-device-related infection

Alexandra Wallimann, Yvonne Achermann, Ciara Ferris, Mario Morgenstern, Martin Clauss, Vincent Stadelmann, Hannes Andreas Rüdiger, Liam O'Mahony, and Thomas Fintan Moriarty

Related authors

Management of fracture-related infection in low-resource settings in Africa: recommendations and guidelines from an international expert group
Loïc Fonkoué, Elizabeth K. Tissingh, Leonard C. Marais, Mbonisi Malaba, Kidanemariam Abrha, Jamie Ferguson, Mario Morgenstern, Olivier Cornu, Maritz Laubscher, Randy Buzisa Mbuku, George W. Galiwango, Matthijs Botman, Justyna Wojno, Mtebe Venance Majigo, Claude Martin Jr., William James Harrison, Alexander Thomas Schade, Kebba Marenah, Malvern Nyamutora, Phiona E. Namale, Vuyisa Mdingi, and Martin McNally
J. Bone Joint Infect., 11, 401–411, https://doi.org/10.5194/jbji-11-401-2026,https://doi.org/10.5194/jbji-11-401-2026, 2026
Short summary
Bone transport in the management of fracture-related infection: current concepts and innovations
Willem-Jan Metsemakers, Austin T. Fragomen, Mario Morgenstern, Steffen B. Rosslenbroich, Stephen M. Quinnan, Pablo S. Corona, Mitchell Bernstein, and Kevin Tetsworth
J. Bone Joint Infect., 11, 191–206, https://doi.org/10.5194/jbji-11-191-2026,https://doi.org/10.5194/jbji-11-191-2026, 2026
Short summary
Combined analysis of host immune response, biofilm genes, and 16S rRNA detection in fracture-related infection: an observational cohort study
Melissa Depypere, Jonathan Sliepen, Jolien Onsea, Yves Debaveye, T. Fintan Moriarty, Elena Della Bella, Emmanuel André, Johan Van Weyenbergh, and Willem-Jan Metsemakers
J. Bone Joint Infect., 11, 161–173, https://doi.org/10.5194/jbji-11-161-2026,https://doi.org/10.5194/jbji-11-161-2026, 2026
Short summary
Treatment of periprosthetic joint infection – outcomes following algorithm-guided treatment at a multidisciplinary referral centre
Christian Merz, Jan Klaas, Rik Osinga, Parham Sendi, Richard Alexander Kuehl, Mario Morgenstern, and Martin Clauss
J. Bone Joint Infect., 11, 113–121, https://doi.org/10.5194/jbji-11-113-2026,https://doi.org/10.5194/jbji-11-113-2026, 2026
Short summary
Gentamicin fails to eradicate Staphylococcus aureus biofilm in vitro, even in combination with rifampin
Willemijn Boot, Michel Schläppi, Virginia Post, T. Fintan Moriarty, and Peter Wahl
J. Bone Joint Infect., 11, 65–76, https://doi.org/10.5194/jbji-11-65-2026,https://doi.org/10.5194/jbji-11-65-2026, 2026
Short summary

Cited articles

Achermann, Y., Eigenmann, K., Ledergerber, B., Derksen, L., Rafeiner, P., Clauss, M., Nüesch, R., Zellweger, C., Vogt, M., and Zimmerli, W.: Factors associated with rifampin resistance in staphylococcal periprosthetic joint Infections (PJI): A matched case–control study, Infection, 41, 431–437, https://doi.org/10.1007/s15010-012-0325-7, 2013. 
Goldstein, B. P.: Resistance to Rifampicin: A Review, J. Antibiot., 67, 625–630, https://doi.org/10.1038/ja.2014.107, 2014. 
Hellmark, B., Unemo, M., Nilsdotter-Augustinsson, Å., and Söderquist, B.: Antibiotic Susceptibility among Staphylococcus Epidermidis Isolated from Prosthetic Joint Infections with Special Focus on Rifampicin and Variability of the RpoB Gene, Clin. Microbiol. Infec., 15, 238–244, https://doi.org/10.1111/j.1469-0691.2008.02663.x, 2009. 
Ju, O., Woolley, M., and Gordon, D.: Emergence and Spread of Rifampicin-Resistant, Methicillin-Resistant Staphylococcus Aureus during Vancomycin–Rifampicin Combination Therapy in an Intensive Care Unit, Eur. J. Clin. Microbiol. Infect. Dis., 25, 61–62, https://doi.org/10.1007/s10096-005-0063-1, 2006. 
Lai, C. C., Che-Kim, T., Sheng-Hsiang, L., Chun-Hsing, L., Yu-Tsung, H., and Po-Ren, H.: Emergence of rifampicin resistance during rifampicin-containing treatment in elderly patients with persistent methicillin-resistant staphylococcus aureus bacteremia, J. Am. Geriatr. Soc., 58, 1001–1003, https://doi.org/10.1111/j.1532-5415.2010.02842.x, 2010. 
Download
Short summary
Skin commensal bacteria such as staphylococci are often the source of orthopaedic-device-related infections. Rifampicin is a widely used antibiotic in the treatment of these infections. The results of this study show that oral rifampicin therapy leads to a consistent and persistent induction of resistance in commensal staphylococci on the skin and in the nose for a prolonged time. 
Share